Patheon Inc. announces final court approval of arrangement

TORONTO, March 10, 2014 /CNW/ - Patheon Inc. (TSX: PTI) ("Patheon") announced 
today that the Ontario Superior Court of Justice (Commercial List) (the 
"Court") has issued a final order approving Patheon's previously announced 
statutory plan of arrangement (the "Arrangement") under the Canada Business 
Corporations Act ("CBCA") pursuant to which JLL/Delta Patheon Holdings, L.P. 
("Newco"), which is sponsored by an entity controlled by an affiliate of JLL 
Partners Inc. and Koninklijke DSM N.V., will indirectly acquire all of the 
issued and outstanding restricted voting shares of Patheon. In issuing the 
final order, the Court has determined that the Arrangement is fair and 
reasonable in accordance with the requirements of the CBCA. 
It is expected that the Arrangement will be completed on Tuesday, March 11, 
2014, assuming the satisfaction or waiver of certain customary conditions. 
About Patheon Inc. 
Patheon Inc. is a leading provider of contract development and commercial 
manufacturing services to the global pharmaceutical industry for a full array 
of solid and sterile dosage forms. Through the company's recent acquisition of 
Banner Pharmacaps - a market leader in soft gelatin capsule technology - 
Patheon now also includes a proprietary products and technology business. 
Patheon provides the highest quality products and services to approximately 
300 of the world's leading pharmaceutical and biotechnology companies. The 
company's integrated network consists of 15 locations, including 12 commercial 
contract manufacturing facilities and 9 development centers across North 
America and Europe. Patheon enables customer products to be launched with 
confidence anywhere in the world. For more information visit 
Forward-Looking Statements 
This press release contains "forward-looking information" or "forward-looking 
statements" within the meaning of applicable Canadian securities laws, 
including statements regarding the proposed transaction and expected timing of 
the transaction, which forward-looking statements may use forward-looking 
terminology such as "may", "will", "expect", "anticipate", "believe", 
"continue", "potential", or the negative thereof or other variations thereof 
or comparable terminology. Such forward-looking statements may include, 
without limitation, statements regarding the completion of the proposed 
transaction and other statements that are not historical facts. 
These forward-looking statements reflect beliefs and assumptions which are 
based on Patheon's perception of current conditions and expected future 
developments, as well as other factors management believes are appropriate in 
the circumstances. Patheon's beliefs and assumptions may prove to be 
inaccurate and consequently Patheon's actual results could differ materially 
from the expectations set out herein. 
While such forward-looking statements are expressed by Patheon in good faith 
and believed by Patheon to have a reasonable basis, they are subject to 
important risks and uncertainties including, without limitation, risks and 
uncertainties relating to the transaction and financing thereof, and the 
satisfaction or waiver of certain other conditions contemplated by the 
arrangement agreement dated November 18, 2013 between Patheon and Newco. As a 
result of these risks and uncertainties, the proposed transaction could be 
modified, restructured or may not be completed, and the results or events 
predicted in these forward-looking statements may differ materially from 
actual results or events. These forward-looking statements are not guarantees 
of future performance, given that they involve risks and uncertainties. 
Patheon is not affirming or adopting any statements made by any other person 
in respect of the proposed transaction and expressly disclaims any intention 
or obligation to update or revise any forward-looking statements, whether as a 
result of new information, future events or otherwise, except in accordance 
with applicable securities laws or to comment on expectations of, or 
statements made by any other person in respect of the proposed transaction. 
Cautionary Statement 
No stock exchange, securities commission or other regulatory authority has 
approved or disapproved the information contained herein.

SOURCE  Patheon Inc. 
 Patheon Inc. Tel: (919) 226-3200 
To view this news release in HTML formatting, please use the following URL: 
CO: Patheon Inc.
ST: Ontario
-0- Mar/10/2014 16:17 GMT
Press spacebar to pause and continue. Press esc to stop.